NMNAT2 and optic neuritis: We therefore tested an Adeno-associated virus (AAV)-mediated gene therapy strategy (Wang et al., 2020) in the mouse EAE/optic neuritis model and specifically expressed long half-life NMNAT2 mutant (NMNAT2Δex6) (Milde et al., 2013b) in the mouse RGCs in vivo.